Governance Grifols, S.A.

GRF

ES0171996087

Pharmaceuticals

Market Closed - BME Other stock markets 11:37:01 2025-01-15 am EST			After market 03:59:57 pm
8.988 ^EUR	-0.27%		9.063	+0.83%

05:00pm	European Equities Traded in the US as American Depositary Receipts Climb Higher in Wednesday Trading	MT
Jan. 14	European Equities Close Mixed Tuesday; Google Probed by UK Competition Watchdog	MT

Executive Committee: Grifols, S.A.

Manager

Positions heldSince

Nacho Abia

56 year

Chief Executive Officer

2024-03-31

Albert Coma-Cros

Chief Tech/Sci/R&D Officer

2020-12-31

Montserrat Gaja Llamas

59 year

Human Resources Officer

2021-06-30

Fernando Sebastian Rodriguez Haro

46 year

Comptroller/Controller/Auditor

2015-12-31

David Bell

71 year

General Counsel

2003-06-30

Nuria Martín Barnés

66 year

Corporate Secretary

2015-05-28

Montserrat Lloveras Calvo

63 year

Comptroller/Controller/Auditor

1990-12-31

Nuria Pascual Lapeña

62 year

Investor Relations Contact	1995-12-31
Treasurer	-

Composition of the Board of Directors: Grifols, S.A.

Director

CommitteesSince

Thomas Heinrich Glanzmann

66 year

Compensation Committee	2018-12-31
Governance Committee	2018-12-31
Nominating Committee	2018-12-31

Anne-Catherine Berner

61 year

Compensation Committee	2018-12-31
HR Committee	2018-12-31
Audit Committee	2024-07-15
Compensation Committee Chair	2024-07-15

Paul Herendeen

69 year

Audit Committee
Finance Committee	2020-12-13

Susana González Rodríguez

48 year

Compensation Committee	2022-06-09
Nominating Committee	2022-06-09

Tomás Dagá Gelabert

69 year

Compensation Committee	2010-01-24
Nominating Committee	2010-01-24

Montserrat Muñoz Abellana

Audit Committee

2024-07-15

Íñigo Sánchez-Asiaín Mardones

60 year

Audit Committee Chair

Enriqueta Felip Font

60 year

Compensation Committee

2024-07-15

Raimon Grifols Roura

62 year

Director/Board Member

2001-07-26

Victor Grifols Deu

49 year

Director/Board Member

2016-05-29

Albert Coma-Cros

Director/Board Member

2023-12-18

Nacho Abia

56 year

Director/Board Member

2024-02-25

Pascal Ravery

Director/Board Member	2024-12-07
Independent Dir/Board Member	2024-12-07

Latest Appointments: Grifols, S.A.

Grifols, S.A. Announces Board Appointments	Dec. 09	CI
Grifols loses 9% of its stock market value after Brookfield's takeover bid is withdrawn	Nov. 28	RE
GC Biopharma USA Names Sean Zam as Head of Sales and Marketing	Nov. 22	CI
Sector Update: Health Care Stocks Fall Late Afternoon	24-09-25	MT
Grifols, S.A. Announces Board Changes	24-09-23	CI
Flat Footed, Mason Capital Management and Sachem Head Capital Management Teams Up to Ask for a Board Seat at Grifols SA	24-09-20	CI
Biotest Chief Scientific Officer to Step Down	24-08-28	MT

More news

Former Officers and Directors: Grifols, S.A.

Insider

Positions held

SinceUntil

James Costos

Director/Board Member	2020-10-08	2024-09-18
Independent Dir/Board Member	2020-10-08	2024-09-18

Alfredo Arroyo Guerra

Chief Administrative Officer	2010-01-26	2013-05-29
Director of Finance/CFO	2006-12-31	2024-09-15
Director of Research - Fxd Inc	2010-01-26	2010-01-26

Claire Giraut

Director/Board Member	2024-06-13	2024-07-11
Independent Dir/Board Member	2024-06-13	2024-07-11

Carina Szpilka Lázaro

Director/Board Member	2015-05-28	2024-07-11
Independent Dir/Board Member	2015-05-28	2024-07-11

Víctor Grifols Roura

Director/Board Member	2022-10-02	2023-12-18
Chief Executive Officer	1984-12-31	2016-12-31
Chairman	2010-01-24	2022-10-02
President	2010-01-24	2016-12-31

Marilyn Rosa-Bray

Chief Tech/Sci/R&D Officer	2022-05-31	2023-07-10
General Counsel	2022-05-31	2023-07-10

Xavier Sueiras Gil

Chief Tech/Sci/R&D Officer

2017-12-31

2023-02-28

Steven Mayer

Director/Board Member	2023-02-20	-
Chairman	2022-10-02	2023-02-20
Independent Dir/Board Member	2011-01-24	2023-02-20

Antonio Martínez Martínez

Chief Tech/Sci/R&D Officer

2019-12-31

2022-06-30

Joseph Schachle

Corporate Officer/Principal

2017-07-31

2021-08-31

Mateo Florencio Borrás Humbert

Human Resources Officer

2010-01-26

2021-05-31

Luís Isasi Fernández de Bobadilla

Director/Board Member	2011-05-24	2020-10-08
Independent Dir/Board Member	2011-05-23	2020-10-08

Edgar Jannotta

Director/Board Member	2010-01-24	2015-06-04
Independent Dir/Board Member	2011-06-01	2015-06-04

Marla E. Salmon

Director/Board Member	2014-05-29	-
Independent Dir/Board Member	2014-05-29	-

Carsten Schroeder

Corporate Officer/Principal

2013-12-31

Belén Villalonga Morenés

Director/Board Member	2013-05-23	-
Independent Dir/Board Member	2013-05-23	-

Brett Ingersoll

Director/Board Member	2011-01-27	-
Independent Dir/Board Member	2011-01-24	-

Christian Purslow

Director/Board Member	2010-01-26	-
Independent Dir/Board Member	-	-

Anna Veiga Lluch

Director/Board Member	2008-12-08	-
Independent Dir/Board Member	2008-12-08	-

Eva Bastida Tubau

Chief Tech/Sci/R&D Officer	2006-12-31	-
Corporate Officer/Principal	2012-02-21	-

José Antonio Grifols Gras

Director/Board Member

2000-01-19

Francisco Javier Jorba Ribes

Corporate Officer/Principal

1994-12-31

Juan Ignacio Twose Roura

Director/Board Member	2010-01-24	-
Corporate Officer/Principal	2010-01-28	2013-12-31

Carlos Roura Fernandez

Corporate Officer/Principal

2010-09-27

Antonio Viñes Páres

Corporate Officer/Principal

2010-09-27

Ramón Riera Roca

Director/Board Member	2000-03-31	-
Corporate Officer/Principal	2010-11-22	2012-02-21
Sales & Marketing	2010-01-26	-

Javier Roura Fernandez

Director of Finance/CFO	2010-01-26	-
Corporate Officer/Principal	2010-11-22	2012-02-21

Christopher Hanna

Director/Board Member

Josep Antoni Grifols Roig

Founder

1940-11-17

Age distribution of managers

Parity Men Women

Male	15
Female	9

Of which Executive Committee

Male	4
Female	4

Of which Directors

Male	10
Female	3

ESG MSCI

BBB

ESG

Environment

Social

Governance

Controversy

Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows: - products derived from plasma (84.3%): products for use by the pharmaceutical and biotechnology industries; - diagnostic machines and reagents (10.2%): in vitro hemophilic diagnostic equipment, coagulation analyzers, infectious serology reagents, etc. for use primarily by blood banks and transfusion centers; - hospital products (2.4%): non-biological surgical products, radiology and nutritional products, etc. for use by hospital pharmacies; - other (3.1%): primarily intermediate biological products and subcontracted manufacturing services. Net sales are distributed geographically as follows: Spain (5.5%), European Union (13.6%), the United States and Canada (59.1%) and other (21.8%).

Employees

23,000

Sector

Pharmaceuticals

Calendar

2025-02-26 - Q4 2024 Earnings Release (Projected)

More about the company